Functionally, we showed that expression of CBFB-MYH11 fusion protein, like knockdown of DNMT3A, significantly up-regulated a common group of genes in K562 cells, some of which are involved in AML progression. The gene discussed is CBFB; the disease is acute myeloid leukemia.